Cas:105-24-8 1-cyclopent-2-en-1-ylpropan-2-one manufacturer & supplier

We serve Chemical Name:1-cyclopent-2-en-1-ylpropan-2-one CAS:105-24-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-cyclopent-2-en-1-ylpropan-2-one

Chemical Name:1-cyclopent-2-en-1-ylpropan-2-one
CAS.NO:105-24-8
Synonyms:1-Cyclopent-2-enylpropan-2-one;2-Cyclopentenyl-1-acetone;EINECS 203-280-4;cyclopent-2-enyl-acetone;2-cyclopentene-1-acetone;1-cyclopent-2-enylacetone;Cyclopent-2-enyl-aceton
Molecular Formula:C8H12O
Molecular Weight:124.18000
HS Code:2914299000

Physical and Chemical Properties:
Melting point:N/A
Boiling point:178.2ºC at 760 mmHg
Density:0.932g/cm3
Index of Refraction:1.462
PSA:17.07000
Exact Mass:124.08900
LogP:1.93170

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1993
Packing Group:


Contact us for information like 1-Cyclopent-2-enylpropan-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cyclopent-2-enyl-aceton physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-cyclopentene-1-acetone Use and application,Cyclopent-2-enyl-aceton technical grade,usp/ep/jp grade.


Related News: He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. 1-cyclopent-2-en-1-ylpropan-2-one manufacturer Inceptua has global operations with local offices across Europe, USA, and Asia 1-cyclopent-2-en-1-ylpropan-2-one supplier Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology. 1-cyclopent-2-en-1-ylpropan-2-one vendor Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle �C from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products. 1-cyclopent-2-en-1-ylpropan-2-one factory Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology.